NCL Technology Ventures Ltd. — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Azadyneazadyne.cominMar 2019
Azadyne is a UK biotech company and spin-out from Trinity College Dublin developing therapeutics based on tRNA modification and epigenetic regulation of cellular protein synthesis.
BiotechDeep Tech
Vincent KellyStephen Connonin
BoardJason Rutt
Co-investors24 Haymarket
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


